313 related articles for article (PubMed ID: 17125499)
1. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
[TBL] [Abstract][Full Text] [Related]
2. The role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1.
Peacocke J; Lotz Z; de Beer C; Roux P; Mall AS
Virol J; 2012 Aug; 9():177. PubMed ID: 22929306
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.
Habte HH; de Beer C; Lotz ZE; Roux P; Mall AS
Virol J; 2010 Oct; 7():269. PubMed ID: 20946627
[TBL] [Abstract][Full Text] [Related]
4. The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
McQuaid IK; Dorfman JR; Mall AS
Virology; 2021 Jan; 553():1-8. PubMed ID: 33190061
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an inhibition assay.
Habte HH; de Beer C; Lotz ZE; Tyler MG; Kahn D; Mall AS
Neonatology; 2008; 93(3):162-70. PubMed ID: 17878743
[TBL] [Abstract][Full Text] [Related]
6. Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.
Wickström C; Christersson C; Davies JR; Carlstedt I
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):421-8. PubMed ID: 11023828
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori.
Silva DG; Stevens RH; Macedo JM; Hirata R; Pinto AC; Alves LM; Veerman EC; Tinoco EM
Arch Oral Biol; 2009 Jan; 54(1):86-90. PubMed ID: 18817906
[TBL] [Abstract][Full Text] [Related]
8. Salivary gel-forming mucin MUC5B--a nutrient for dental plaque bacteria.
Wickström C; Svensäter G
Oral Microbiol Immunol; 2008 Jun; 23(3):177-82. PubMed ID: 18402602
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay.
Habte HH; de Beer C; Lotz ZE; Tyler MG; Schoeman L; Kahn D; Mall AS
Virol J; 2008 May; 5():59. PubMed ID: 18489743
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of polymeric salivary mucins: no evidence for MUC19 in human saliva.
Rousseau K; Kirkham S; Johnson L; Fitzpatrick B; Howard M; Adams EJ; Rogers DF; Knight D; Clegg P; Thornton DJ
Biochem J; 2008 Aug; 413(3):545-52. PubMed ID: 18426393
[TBL] [Abstract][Full Text] [Related]
11. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7.
Rousseau K; Wickstrom C; Whitehouse DB; Carlstedt I; Swallow DM
Hybrid Hybridomics; 2003 Oct; 22(5):293-9. PubMed ID: 14678646
[TBL] [Abstract][Full Text] [Related]
12. Purified human breast milk MUC1 and MUC4 inhibit human immunodeficiency virus.
Mthembu Y; Lotz Z; Tyler M; de Beer C; Rodrigues J; Schoeman L; Mall AS
Neonatology; 2014; 105(3):211-7. PubMed ID: 24503884
[TBL] [Abstract][Full Text] [Related]
13. Mucins MUC5B and MUC7 in minor salivary gland secretion of children and adults.
Sonesson M; Wickström C; Kinnby B; Ericson D; Matsson L
Arch Oral Biol; 2008 Jun; 53(6):523-7. PubMed ID: 18282555
[TBL] [Abstract][Full Text] [Related]
14. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
[TBL] [Abstract][Full Text] [Related]
15. Degradation of MUC7 and MUC5B in human saliva.
Takehara S; Yanagishita M; Podyma-Inoue KA; Kawaguchi Y
PLoS One; 2013; 8(7):e69059. PubMed ID: 23874867
[TBL] [Abstract][Full Text] [Related]
16. Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
Mall AS; Habte H; Mthembu Y; Peacocke J; de Beer C
Virol J; 2017 Oct; 14(1):192. PubMed ID: 28985745
[TBL] [Abstract][Full Text] [Related]
17. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B.
Nielsen PA; Bennett EP; Wandall HH; Therkildsen MH; Hannibal J; Clausen H
Glycobiology; 1997 Apr; 7(3):413-9. PubMed ID: 9147051
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of salivary mucins MUC5B and MUC7 in human labial glands.
Piras M; Hand AR; Tore G; Ledda GP; Piludu M
Eur J Oral Sci; 2010 Feb; 118(1):14-8. PubMed ID: 20156260
[TBL] [Abstract][Full Text] [Related]
19. MUC7 Level As A New Saliva Risk Factor For Dental Caries In Adult Patients.
Szkaradkiewicz-Karpińska AK; Ronij A; Goślińska-Kuźniarek O; Przybyłek I; Szkaradkiewicz A
Int J Med Sci; 2019; 16(2):241-246. PubMed ID: 30745804
[No Abstract] [Full Text] [Related]
20. MUC5B glycosylation in human saliva reflects blood group and secretor status.
Thomsson KA; Schulz BL; Packer NH; Karlsson NG
Glycobiology; 2005 Aug; 15(8):791-804. PubMed ID: 15814823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
